Mirum Pharmaceuticals, Inc. (MIRM) stock
MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$92.49+0.54 (+0.59%)
Close on Nov 18, 2026Market cap $6.01BP/E –Yield –
Mirum Pharmaceuticals operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Mirum Pharmaceuticals's operating income for the twelve months ending Jun 30, 2026 was -$833.97M. For fiscal 2025 it was -$22.14M. The highest annual figure on record is -$22.14M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.14M | – |
| FY2024 | Dec 31, 2024 | -$87.61M | – |
| FY2023 | Dec 31, 2023 | -$109.15M | – |
| FY2022 | Dec 31, 2022 | -$131.22M | – |
| FY2021 | Dec 31, 2021 | -$173.41M | – |
| FY2020 | Dec 31, 2020 | -$104.30M | – |
| FY2019 | Dec 31, 2019 | -$54.74M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$42.54M | – |
| Q1 FY2026 | Mar 31, 2026 | -$789.47M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.57M | – |
| Q3 FY2025 | Sep 30, 2025 | $2.60M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.99M | – |
| Q1 FY2025 | Mar 31, 2025 | -$15.18M | – |
| Q4 FY2024 | Dec 31, 2024 | -$24.22M | – |
| Q3 FY2024 | Sep 30, 2024 | -$12.68M | – |
| Q2 FY2024 | Jun 30, 2024 | -$24.23M | – |
| Q1 FY2024 | Mar 31, 2024 | -$26.47M | – |
| Q4 FY2023 | Dec 31, 2023 | -$32.59M | – |
| Q3 FY2023 | Sep 30, 2023 | -$25.15M | – |
| Q4 FY2022 | Dec 31, 2022 | -$34.16M | – |
| Q3 FY2022 | Sep 30, 2022 | -$32.88M | – |
| Q2 FY2022 | Jun 30, 2022 | -$31.44M | – |
| Q1 FY2022 | Mar 31, 2022 | -$32.74M | – |
| Q4 FY2021 | Dec 31, 2021 | -$45.58M | – |
| Q3 FY2021 | Sep 30, 2021 | -$42.82M | – |
| Q2 FY2021 | Jun 30, 2021 | -$37.40M | – |
| Q1 FY2021 | Mar 31, 2021 | -$47.61M | – |
| Q4 FY2020 | Dec 31, 2020 | -$36.95M | – |
| Q3 FY2020 | Sep 30, 2020 | -$21.72M | – |
| Q2 FY2020 | Jun 30, 2020 | -$23.60M | – |
| Q1 FY2020 | Mar 31, 2020 | -$22.03M | – |
| Q4 FY2019 | Dec 31, 2019 | -$18.66M | – |
| Q3 FY2019 | Sep 30, 2019 | -$15.87M | – |
| Q2 FY2019 | Jun 30, 2019 | -$14.03M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.18M | – |
| Q3 FY2018 | Sep 30, 2018 | -$65.00K | – |
See a number that looks wrong?